S. Drury

CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients.

J. Cuzick, M. Dowsett, I. Šestak, 2012, Journal of the National Cancer Institute.

Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients

A. Howell, M. Dowsett, D. Evans, 2012, Breast Cancer Research and Treatment.